Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glulisine vs Lispro in Children and Adolescents with Type 1 Diabetes
NCT00115570Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Primary completion
- Nov 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin glulisine in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Change in total glycated hemoglobin at 26 weeks. Started Apr 2005; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00115570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115570.